
Medon Pharmaceuticals Private Limited
Pharmaceutical trading company based in Ranchi, Jharkhand since 2016.
Pharmaceutical trading company based in Ranchi, Jharkhand since 2016.
Medon Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2016 (Eight years and six months 8 days old ). Its registered office is in Ranchi, Jharkhand, India.
The Corporate was formerly known as Medon Pharmaceuticlas Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 M.
Kaushlendra Kumar, Kamlawati Devi, Srikant Kumar, and Five other members serve as directors at the Company.
Ranchi, Jharkhand, India
+91-XXXXXXXXXX
-
U74999JH2016PTC009109
009109
Private Limited Indian Non-Government Company
26 Aug 2016
30 Sep 2023
31 Mar 2023
Unlisted
Roc Jharkhand
Medon Pharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antiepileptic Drugs, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Surgical & ICU Equipments, Nebulizer Machine & Parts, Psychotherapeutic Agents, Common Disease Medicines, Pharmaceutical Capsules, Allopathic Cough Syrup.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srikant Kumar ![]() | Director | 26-Aug-2016 | Current |
Ankur Awathi ![]() | Director | 10-Jun-2020 | Current |
Kaushlendra Kumar ![]() | Director | 26-Aug-2016 | Current |
Kamlawati Devi ![]() | Director | 26-Aug-2016 | Current |
Riches Kumar ![]() | Director | 17-Dec-2020 | Current |
Manju Awasthi ![]() | Director | 10-Jun-2020 | Current |
Medon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.63% decrease. The company also saw a substantial fall in profitability, with a 59.47% decrease in profit. The company's net worth moved up by a moderate rise of 1.04%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Medon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Kamlawati Devi is a mutual person
Kaushlendra Kumar and Kamlawati Devi are mutual person
Srikant Kumar and Riches Kumar are mutual person
Srikant Kumar is a mutual person
Riches Kumar is a mutual person
Ankur Awathi is a mutual person
₹2.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
02 May 2017 | Others | ₹2.00 M | Open |
Medon Pharmaceuticals has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Medon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jharkhand.
Riches Kumar was appointed as a Director was appointed as a Director on 17 Dec 2020 & has been associated with this company since 4 years 2 months .
Manju Awasthi was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 4 years 8 months .
A charge with Others amounted to Rs. 2.00 M with Charge ID 100101079 was registered on 02 May 2017.
Kaushlendra Kumar was appointed as a Director was appointed as a Director on 26 Aug 2016 & has been associated with this company since 8 years 6 months .
Medon Pharmaceuticals Private Limited was incorporated on 26 Aug 2016.
The authorized share capital of Medon Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 8 directors are associated with Medon Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medon Pharmaceuticals Private Limited is H.No. 235 Bhola Chaubey Gali, Chutia India, Ranchi, Jharkhand, 834001.
The corporate identification number (CIN) of Medon Pharmaceuticals Private Limited is U74999JH2016PTC009109 and the company number is 009109 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Medon Pharmaceuticals Private Limited has fallen by -21.63%.
The financial reports for the fiscal year 2023 indicates that The net worth of Medon Pharmaceuticals Private Limited has experienced an upsurge of 1.04%.
As per the financial statements for fiscal Year 2023, The total open charges for Medon Pharmaceuticals Private Limited amount to ₹ 2.00 M.
The most recent Balance Sheet for Medon Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.